Effects of leptin replacement therapy on pancreatic β-cell function in patients with lipodystrophy.
Ontology highlight
ABSTRACT: OBJECTIVE Leptin administration is known to directly modulate pancreatic β-cell function in leptin-deficient rodent models. However, human studies examining the effects of leptin administration on β-cell function are lacking. In this study, we examined the effects (16-20 weeks) of leptin replacement on β-cell function in patients with lipodystrophy. RESEARCH DESIGN AND METHODS In a prospective, open-label, currently ongoing study, we studied the effects of leptin replacement on β-cell function in 13 patients with congenital or acquired lipodystrophy. Insulin secretory rate (ISR) was calculated by C-peptide deconvolution from plasma glucose and C-peptide levels measured during oral glucose tolerance tests (OGTTs) performed at baseline and after 16-20 weeks of leptin replacement. β-Cell gluc
SUBMITTER: Muniyappa R
PROVIDER: S-EPMC3964492 | biostudies-literature | 2014 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA